Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 15 | −8 |
| SharesConverted for a 1-for-25 split | 141.5K | 6.24K | 35.6K | −99.7K (−73.7%) |
| Value | $778.4K | $34.3K | $63.8K | −$680.3K (−91.4%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Fiduciary Trust Co | 5,879 | $10.5K | 0.00% |
| Vanguard Capital Management LLC | 361 | $646 | 0.00% |
| Caitong International Asset Management Co., Ltd | 15 | $27 | 0.00% |
| Northwestern Mutual Wealth Management Co | 4 | $7 | 0.00% |
Sold out (12)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Armistice Capital, LLC | 2,554,442 | $562.0K |
| Citadel Advisors LLC | 219,621 | $48.3K |
| Jane Street Group, LLC | 121,841 | $26.8K |
| Northern Trust Corp | 65,979 | $14.5K |
| Virtu Financial LLC | 63,827 | $14.0K |
| XTX Topco Ltd | 52,097 | $11.5K |
| StoneX Group Inc. | 19,451 | $4.28K |
| Two Sigma Securities, LLC | 17,074 | $3.76K |
| Susquehanna International Group, LLP | 12,087 | $2.66K |
| Private Management Group Inc | 10,000 | $2.20K |
| Bank of America Corp | 205 | $45 |
| Citigroup Inc | 1 | $0 |
Not filed for Q1 2026 yet (1)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 156,024 | $34.3K |